ENTRY       D04670                      Drug
NAME        Laronidase (USAN);
            Laronidase (genetical recombination) (JAN);
            Aldurazyme (TN)
PRODUCT     ALDURAZYME (Genzyme Corporation)
FORMULA     C3567H5645N921O1261S12P4
EXACT_MASS  82067.1507
MOL_WEIGHT  82116.0773
SEQUENCE    AEAPHLVHVD AARALWPLRR FWRSTGFCPP LPHSQADQYV LSWDQQLNLA YVGAVPHRGI
            KQVRTHWLLE LVTTRGSTGR GLSYNFTHLD GYLDLLRENQ LLPGFELMGS ASGHFTDFED
            KQQVFEWKDL VSSLARRYIG RYGLAHVSKW NFETWNEPDH HDFDNVSMTM QGFLNYYDAC
            SEGLRAASPA LRLGGPGDSF HTPPRSPLSW GLLRHCHDGT NFFTGEAGVR LDYISLHRKG
            ARSSISILEQ EKVVAQQIRQ LFPKFADTPI YNDEADPLVG WSLPQPWRAD VTYAAMVVKV
            IAQHQNLLLA NTTSAFPYAL LSNDNAFLSY HPHPFAQRTL TARFQVNNTR PPHVQLLRKP
            VLTAMGLLAL LDEEQLWAEV SQAGTVLDSN HTVGVLASAH RPQGPADAWR AAVLIYASDD
            TRAHPNRSVA VTLRLRGVPP GPGLVYVTRY LDNGLCSPDG EWRRLGRPVF PTAEQFRRMR
            AAEDPVAAAP RPLPAGGRLT LRPALRLPSL LLVHVCARPE KPPGQVTRLR ALPLTQGQLV
            LVWSDEHVGS KCLWTYEIQF SQDGKAYTPV SRKPSTFNLF VFSPDTGAVS GSYRVRALDY
            WARPGPFSDP VPYLEVPVPR GPPSPGNP
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB05
            Product: D04670<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (L-iduronidase)
  DISEASE   Mucopolysaccharidosis I [DS:H00128]
  TYPE      Enzyme replacement therapy product
TARGET      IDUA* [HSA_VAR:3425v1] [HSA:3425] [KO:K01217]
  PATHWAY   hsa00531(3425)  Glycosaminoglycan degradation
            hsa04142(3425)  Lysosome
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB05 Laronidase
                  D04670  Laronidase (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Laronidase
               D04670  Laronidase (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D04670  Laronidase (USAN); Laronidase (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Glycosidases
                IDUA* [HSA_VAR:3425v1]
                 D04670  Laronidase (USAN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04670
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04670
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D04670
DBLINKS     CAS: 210589-09-6
            PubChem: 47206509
///
